Specialist consultation improves underdiagnosis of surgical adrenal incidentaloma: a TriNetX database investigation

Read full text Summarise with VIRAT
Authors: Aaron R. Hochberg, Monika Khanna Shirodkar, Brian H. Im, Xiaoying Deng, Fitsum T. Hailemariam, Sohan S. Shah, Rasheed A. M. Thompson, Francisco Aguirre, Patrick T. Gomella, Mihir S. Shah, Costas D. Lallas, Adam R. Metwalli
Cited by: 0
References: 27

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

OBJECTIVES: Despite practice guidelines recommending hormonal testing for all cases of incidentally discovered adrenal adenomas (incidentalomas), only 30% of patients receive laboratory workup. This study sought to evaluate hormonal testing and adrenal surgery rates in incidentaloma patients seen by a specialist (endocrinologist, nephrologist, urologist, or general surgeon), compared to those not seen by a specialist. METHODS: We identified incidentaloma cases by querying the TriNetX Research Network for all adult patients with an unspecified adrenal mass occurring within 1 month following abdominal imaging. We compared those seen by a specialist against those not following an incidentaloma diagnosis. Primary outcomes were rates of hormonal testing and adrenal gland surgery. RESULTS: Of 132,217 incidentaloma patients, 1054 (0.7%) received a specialist consultation. Referral to a specialist was associated with increased hormonal testing (49.5% vs. 28.0%, p < 0.0001) and adrenal surgery (6.3% vs. 3.6%, p < 0.0001). Surgery rates were similar among those who received hormonal testing, regardless of specialist consultation (12.6% vs. 13.3%, p = 0.8445). Of all incidentaloma patients, 6765 (5.2%) proceeded to adrenal surgery. CONCLUSIONS: Patients receiving specialist services experienced more hormonal testing and treatment with surgery. Surgery rates did not differ among those undergoing any hormonal evaluation, regardless of specialist status, indicating that about 13% of incidentaloma patients will require adrenal surgery. Applying this rate suggests that nearly 14,000 incidentaloma patients in TriNetX did not receive surgery despite likely meeting criteria, a significant failure in treatment. Further, prospective studies are needed to investigate practice patterns and expose reasons for the lack of progression to evaluation or treatment.

Fields of Study & Subjects

Adrenal and Paraganglionic Tumors Adrenal Hormones and Disorders Pituitary Gland Disorders and Treatments

Publication details

Journal / source
Canadian Journal of Urology
Volume
33
Issue
4
Pages
931–941
Publication date
21 August 2026
Language
EN